Metabolic Acidosis Clinical Trial
— POKACIDOfficial title:
Incidence of Postoperative Ketosis and Metabolic Acidosis
The aim of this study is to define the incidence and nature of acidosis after major surgery using Figge's equations to directly measure acidosis. This study will also aim to compare the ability of indirect measures (base deficit, anion gap,corrected anion gap and lactate) to identify the presence of tissue acids in this population. The incidence of postoperative ketoacidosis as a contributor to tissue acidosis will be assessed through the use of point of care urinalysis.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | August 2013 |
Est. primary completion date | August 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients who have undergone major cancer surgery - Patients who have an arterial line in place - Patients who have a urinary catheter in place - Patients who will be admitted to intensive care following surgery - Adults >18 years - Adults who are capable of reading and understanding English Exclusion Criteria: - Patient refusal - Patients without an arterial line or urinary catheter in place - Patients receiving glucose / sliding scale insulin for management of diabetes mellitus |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United Kingdom | Royal Marsden NHS Foundation Trust | London | England |
Lead Sponsor | Collaborator |
---|---|
Royal Marsden NHS Foundation Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of tissue acidosis, defined as tissue acids > 5mEq/L (Figge's equation) within one hour of completion of surgery | 31/08/13 | No | |
Secondary | Incidence of metabolic acidosis, defined by base deficit . 2 mEq/L (Henderson-Hasselback) within one hour of completion of surgery. | 31/08/13 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Completed |
NCT03317444 -
Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease
|
Phase 3 | |
Recruiting |
NCT05582824 -
Lactate Metabolism in the Hypoperfused Critically Ill
|
||
Active, not recruiting |
NCT04010630 -
Sodium Bicarbonate for the Treatment of Severe Metabolic Acidosis With Moderate or Severe Acute Kidney Injury in ICU
|
N/A | |
Completed |
NCT02303548 -
Bicarbonate in Patients With Out-of-hospital Cardiac Arrest
|
Phase 2 | |
Completed |
NCT01452412 -
Alkali Therapy in Chronic Kidney Disease
|
Phase 2/Phase 3 | |
Terminated |
NCT03710291 -
Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis
|
Phase 3 | |
Completed |
NCT02476253 -
Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill
|
Phase 3 | |
Completed |
NCT05940935 -
The Relationship of Developing Metabolic Acidosis With Antiepleptic Drugs in Craniotomy Operations
|
||
Withdrawn |
NCT03846258 -
High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy
|
Phase 4 | |
Completed |
NCT05970094 -
Reduction of Metabolic Acidosis in Patients With Chronic Kidney Disease in Stage 4 and 5
|
N/A | |
Recruiting |
NCT05784389 -
Reduction of Metabolic Acidosis in Patients With Chronic Kidney Disease in Stage 4 and 5
|
N/A | |
Terminated |
NCT04727528 -
Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease
|
Phase 3 | |
Completed |
NCT02098356 -
Comparison of High Versus Low Bicarbonate Hemodialysis
|
N/A | |
Recruiting |
NCT03897101 -
Inflammation and Metabolic Acidosis at Birth (AGAIN: AutophaGy AcIdosis Newborn)
|
||
Terminated |
NCT01894594 -
Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease
|
Phase 1 | |
Completed |
NCT01075750 -
Perioperative Fluid Management in Patients Receiving Cadaveric Renal Transplants
|
N/A | |
Completed |
NCT01295190 -
Substitution of Propofol by Sevoflurane During Pediatric Cardiopulmonary Bypass
|
N/A | |
Completed |
NCT01293266 -
Effect of Propofol and Sevoflurane on Lactate During Anesthesia for Pediatric Heart Catheterisation
|
N/A | |
Completed |
NCT05147051 -
Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients
|
Phase 2 |